177 related articles for article (PubMed ID: 15718313)
1. Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.
Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Tham YL; Kalidas M; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; Lewis MT; Wong H; O'Connell P
J Clin Oncol; 2005 Feb; 23(6):1169-77. PubMed ID: 15718313
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer.
Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; O'Connell P
Lancet; 2003 Aug; 362(9381):362-9. PubMed ID: 12907009
[TBL] [Abstract][Full Text] [Related]
3. Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer.
Korde LA; Lusa L; McShane L; Lebowitz PF; Lukes L; Camphausen K; Parker JS; Swain SM; Hunter K; Zujewski JA
Breast Cancer Res Treat; 2010 Feb; 119(3):685-99. PubMed ID: 20012355
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of CCT5, RGS3, and YKT6 genes up-regulated in p53-mutated tumors in resistance to docetaxel in human breast cancers.
Ooe A; Kato K; Noguchi S
Breast Cancer Res Treat; 2007 Mar; 101(3):305-15. PubMed ID: 16821082
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
7. Prediction of docetaxel response in human breast cancer by gene expression profiling.
Iwao-Koizumi K; Matoba R; Ueno N; Kim SJ; Ando A; Miyoshi Y; Maeda E; Noguchi S; Kato K
J Clin Oncol; 2005 Jan; 23(3):422-31. PubMed ID: 15659489
[TBL] [Abstract][Full Text] [Related]
8. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer.
Kim SJ; Miyoshi Y; Taguchi T; Tamaki Y; Nakamura H; Yodoi J; Kato K; Noguchi S
Clin Cancer Res; 2005 Dec; 11(23):8425-30. PubMed ID: 16322305
[TBL] [Abstract][Full Text] [Related]
9. Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients.
Chang JC; Makris A; Gutierrez MC; Hilsenbeck SG; Hackett JR; Jeong J; Liu ML; Baker J; Clark-Langone K; Baehner FL; Sexton K; Mohsin S; Gray T; Alvarez L; Chamness GC; Osborne CK; Shak S
Breast Cancer Res Treat; 2008 Mar; 108(2):233-40. PubMed ID: 17468949
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer.
Heys SD; Sarkar T; Hutcheon AW
Expert Opin Pharmacother; 2004 Oct; 5(10):2147-57. PubMed ID: 15461550
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells.
Brown I; Shalli K; McDonald SL; Moir SE; Hutcheon AW; Heys SD; Schofield AC
Breast Cancer Res; 2004; 6(5):R601-7. PubMed ID: 15318941
[TBL] [Abstract][Full Text] [Related]
12. Primary (neoadjuvant) chemotherapy with docetaxel in breast cancer.
Gradishar WJ
Clin Breast Cancer; 2001 Oct; 2 Suppl 1():S31-5. PubMed ID: 11970742
[TBL] [Abstract][Full Text] [Related]
13. Genomic predictors of response to doxorubicin versus docetaxel in primary breast cancer.
Martin M; Romero A; Cheang MC; López García-Asenjo JA; García-Saenz JA; Oliva B; Román JM; He X; Casado A; de la Torre J; Furio V; Puente J; Caldés T; Vidart JA; Lopez-Tarruella S; Diaz-Rubio E; Perou CM
Breast Cancer Res Treat; 2011 Jul; 128(1):127-36. PubMed ID: 21465170
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers.
Tham YL; Gomez LF; Mohsin S; Gutierrez MC; Weiss H; Hilsenbeck SG; Elledge RM; Chamness GC; Osborne CK; Allred DC; Chang JC
Breast Cancer Res Treat; 2005 Dec; 94(3):279-84. PubMed ID: 16261403
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for response to docetaxel in human breast cancers.
Noguchi S
Cancer Sci; 2006 Sep; 97(9):813-20. PubMed ID: 16805818
[TBL] [Abstract][Full Text] [Related]
16. Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial.
Bonnefoi H; Potti A; Delorenzi M; Mauriac L; Campone M; Tubiana-Hulin M; Petit T; Rouanet P; Jassem J; Blot E; Becette V; Farmer P; André S; Acharya CR; Mukherjee S; Cameron D; Bergh J; Nevins JR; Iggo RD
Lancet Oncol; 2007 Dec; 8(12):1071-1078. PubMed ID: 18024211
[TBL] [Abstract][Full Text] [Related]
17. Predicting response to docetaxel neoadjuvant chemotherapy for advanced breast cancers through genome-wide gene expression profiling.
Zembutsu H; Suzuki Y; Sasaki A; Tsunoda T; Okazaki M; Yoshimoto M; Hasegawa T; Hirata K; Nakamura Y
Int J Oncol; 2009 Feb; 34(2):361-70. PubMed ID: 19148470
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer.
Layman RM; Thomas DG; Griffith KA; Smerage JB; Helvie MA; Roubidoux MA; Diehl KM; Newman LA; Sabel MS; Hayman JA; Pierce LJ; Hayes DF; Schott AF
Clin Cancer Res; 2007 Jul; 13(14):4092-7. PubMed ID: 17634534
[TBL] [Abstract][Full Text] [Related]
19. Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (cytoxan) (AC) response and resistance.
Cleator S; Tsimelzon A; Ashworth A; Dowsett M; Dexter T; Powles T; Hilsenbeck S; Wong H; Osborne CK; O'Connell P; Chang JC
Breast Cancer Res Treat; 2006 Feb; 95(3):229-33. PubMed ID: 16322899
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Use of Docetaxel-Containing Adjuvant Chemotherapy Among Chinese Patients with Operable Breast Cancer: A Multicenter Observational Study.
Xie H; Liu J; Yu S; Chen Y; Zheng M; Deng Y; Wang S; Jiang J; Li Y; Li H; Kang H; Zhang C; Zhang GJ; Su F; Cheng A; Wang S
Adv Ther; 2019 Jan; 36(1):131-146. PubMed ID: 30511279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
